PHILADELPHIA — Feb. 23, 2026 — Health Union, the leading digital health company for online community-based activation and data, and solli, the premier community-driven media platform for the pharmaceutical marketing industry, today announced the release of the 2026 Pharma Marketing Pulse Report. Drawing from over 1,500 data points provided by a highly senior cohort of industry leaders, the report offers a definitive roadmap for pharmaceutical brands navigating an increasingly complex intersection of technology, regulation, and trust.
The survey features insights from over 50 veteran pharma marketers, 75% of whom hold Director-level positions or higher. This senior perspective reveals a resilient industry: 80% of respondents expect their marketing budgets to remain stable or increase in 2026, even in the face of regulatory uncertainty and technology-driven shifts.
“The 2026 data shows that as AI changes the way both patients and HCPs consume information, pharma marketers are shifting their focus from simple visibility to verified authority,” said Olivier Chateau, CEO and co-founder of Health Union. “Marketers are no longer just looking for reach; they are prioritizing trusted specialty platforms that can link top-of-funnel engagement to bottom-line results like prescription lift and ROI. By leaning into environments built on lived experience, brands can move beyond simple clicks to find the deep, qualified engagement that drives real outcomes.”
